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1. Introduction 
Vascular diseases are one of the leading causes of significant morbidity and mortality 
worldwide. Vascular diseases not only occur at all levels of vascular tree but also affect 
multiple organs and organ systems. Organ tissue engineering, including vascular tissue 
engineering, has been an area of intense investigation. The current major challenge to these 
approaches has been the inability to vascularize and perfuse in vitro engineered tissue 
constructs. Attempts to provide oxygen and nutrients to cells contained in biomaterial 
constructs have met with varying degrees of success. Engineering a tissue of clinically 
relevant magnitude requires the formation of extensive and stable microvascular networks 
within the tissue (Brey et al., 2005). Since most in vitro engineered tissue constructs do not 
contain the intricate microvascular structures of native tissue, the cells contained in scaffolds 
heavily rely on simple diffusion for oxygenation and nutritional delivery. The majority of 
cells need to be within 100-200 m of a blood supply to receive adequate oxygen and 
nutrients for survival (Carmeliet & Jain, 2000). Otherwise, due to diffusion gradients, the 
cells in the interior regions of the artificial scaffold can experience hypoxia or anoxia and 
undergo cellular degeneration and necrosis. Hence, this necessitates the formation of 
appropriate in vitro three-dimensional (3-D) plexuses of new blood vessels within the pre-
implanted biomaterial constructs through the process of in situ de novo 
vasculogenesis/angiogenesis for organ tissue engineering.  
Development of postnatal new blood vessels occurs essentially by two temporally distinct 
but interrelated processes, vasculogenesis and angiogenesis. Vasculogenesis is the process 
of blood vessel formation occurring by a de novo production of endothelial cells in an 
embryo (primitive vascular network) or a formerly avascular area when endothelial 
precursor cells (angioblasts, hemangioblasts or stem cells) migrate and differentiate in 
response to local cues (such as growth factors and extracellular matrix) to form new intact 
blood vessels (Risau & Flamme, 1995). Angiogenesis refers principally to the sprouting of 
new blood vessels from the differentiated endothelium of pre-existing vessels. These 
vascular trees or plexuses are then pruned, remodeled and extended through 
angiogenesis to become larger caliber vessels (Carmeliet, 2000). In addition, there exists 
yet another unique mechanism of neovascularization, the postnatal vasculogenesis, where 
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new blood vessels are formed by the process of fusion and differentiation of endothelial 
progenitors of bone marrow origin (Valarmathi et al., 2009). This indicates a potential role 
for bone marrow-derived progenitor cells in postnatal neovasculogenesis and/or 
neoangiogenesis. This implies that additional mechanisms besides angiogenesis can occur 
in the adult, and has opened up the possibility to investigate the embryonic origin and 
development of these putative progenitor cells. 
The adult bone marrow contains two subsets of multipotential stem cells, hematopoietic 
stem cells (HSCs) and bone marrow stromal cells or mesenchymal stem cells 
(BMSCs/MSCs). BMSCs are a readily available heterogeneous population of cells that can 
be directed to differentiate into multiple mesenchymal and non-mesenchymal cells either in 
vitro or in vivo (Wakitani et al., 1995; Pittenger et al., 1999; Makino et al., 1999; Fukuda et al., 
2001; Bianco et al., 2001; Valarmathi et al., 2009, 2010). Most noticeably BMSCs have been 
induced to undergo maturation and differentiation towards vascular endothelial and 
smooth muscle cell lineages. Previous reports indicate that BMSCs and bone marrow-
derived multipotent adult progenitor cells (MAPCs) can be differentiated into endothelial-
like cells in vitro and contribute to neoangiogenesis in vivo (Oswald et al., 2004; Reyes et al., 
2002; Al-Khaldi et al., 2003). Additionally, it has been shown that BMSCs can augment 
collateral remodeling and perfusion in ischemic models through paracrine mechanisms 
rather than by cellular incorporation upon local delivery (Kinnaird et al., 2004). Therefore, 
the identification of bone-marrow-derived (hematopoietic and non-hematopoietic stem 
cells) and non-bone-marrow-derived (tissue-resident stem/progenitor cells – adipose, 
neural, heart, skeletal muscle; peripheral and cord blood-derived stem cells) endothelial 
progenitors cells (EPCs) has led to the realization of potential postnatal vasculogenesis 
(Urbich & Dimmeler, 2004).  
For the above mentioned reasons, embryonic, fetal and postnatal stem cells as well as 
various types of progenitor cells, can be a potential cellular source for vascular tissue 
engineering (Levenberg, 2005). However, the source for the early-stage developmental 
cells is restricted. The utility of embryonic stem cells (ESCs) and induced pluripotent stem 
cells (iPSCs) in facilitating vascularized tissue/organ regeneration is still in its incipient 
stages. A number of issues, including a propensity for some implanted ESCs/iPSCs to 
form benign teratomas and/or malignant teratocarcinomas in the regenerating 
tissue/organ, remain to be addressed. In contrast to both ESCs/iPSCs, it has been well 
established that the adult stem cell, BMSCs exhibit multilineage differentiation potential 
in a well-controlled, predictable fashion. Moreover, unlike ESCs derivation, obtaining 
autologous or allogeneic BMSCs is feasible and can potentially be exploited to develop 
tissue-engineered blood vessel constructs for therapeutic purposes. Similarly, when 
compared to bone marrow-derived BMSCs, repeated isolation and rapid expansion of 
sufficient yield of autologous and/or allogeneic non-bone-marrow-derived resident stem 
cells/progenitors, especially from vital organs for routine therapeutic purposes are highly 
constrained. On the contrary, to certain extent autologous and/or allogeneic bone 
marrow-derived BMSCs are amenable for repeated isolation and reasonable in vitro 
expansion from the patients. In addition, the significant advantage of using these BMSCs 
is their low immunogenicity. And these autologous or allogeneic BMSCs have been 
reported to be immunomodulatory and immunotolerogenic both in vitro as well as in 
vivo. (Aggarwal & Pittenger, 2005). Taken together, these data strongly indicate that 
BMSCs can represent the potential cell of choice for adult autologous and/or allogeneic 
stem cell based vascularized tissue regeneration.     
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Extracellular molecules initiate biological signals and play a critical role in the control of 
cellular proliferation, differentiation, and morphogenesis. Many parameters, such as the 
presence and amount of soluble factors such as hormones, growth factors, and cytokines or 
the insoluble factors such as the physical configuration of the matrix which mediate the cell-
cell interactions and cell-matrix interactions, exerts strong influence on the success of 
angiogenic processes in vitro and presumably in vivo (Even-Ram & Yamada, 2005; Carlson, 
2007). The likelihood and ultimate success of in vitro cellular differentiation depends on 
how closer the cell-matrix interactions and relationships’ mimic to those found during 
normal development or regeneration. In vascular tissue engineering, the application of these 
principles in vivo will be important to ensure that the matrix/scaffold to be implanted can 
support endothelial cell proliferation and migration resulting in endothelial tube formation 
(Ingber & Folkman, 1989). The vital issue for realistic clinical application is whether these 
scaffolds with preformed network of endothelial capillaries/microvessels can survive 
implantation into tissue defects and subsequently be able to anastomose to the host 
vasculature. 
We therefore hypothesized that under appropriate in vitro physicochemical 
microenvironmental cues (combination of growth factors and extra cellular matrix, ECM) 
multipotent adult BMSCs could be differentiated into vascular endothelial and smooth 
muscle cell lineages. To test this hypothesis, we characterized the intrinsic vasculogenic 
differentiation potential of adult BMSCs when seeded onto a three-dimensional (3-D) 
tubular scaffold engineered from aligned type I collagen strands and cultured either in 
vasculogenic or non-vasculogenic growth medium. In these culture conditions, BMSCs 
differentiated and matured into both endothelial and smooth muscle/pericyte cell lineages 
and showed microvascular morphogenesis. We also explored the potential of the 3-D model 
system to undergo postnatal de novo vasculogenesis.   
2. Experimental approach 
The differentiation of rat BMSCs was carried out on a 3-D tubular scaffold made up of 
aligned type I collagen-gel fibers. Rat BMSCs were isolated from the tibial and femoral bone 
marrow of adult rats. The BMSCs isolated from the bone marrow were expanded, 
maintained and passaged to make sure that the attached marrow stromal cells were devoid 
of any non-adhering populations of cells. Phenotypic characterization of the BMSCs for cell 
surface markers was performed by confocal microscopy (qualitative evaluation) and single-
color flow cytometry (quantitative analysis). This adherent population of cells were further 
purified and enriched by indirect magnetic cell sorting. The cells were subjected to CD90 
positive selection. The resultant enriched CD90+/CD34-/CD45- fractions were expanded by 
subculturing and subjected to flow cytometric analysis to validate the proper phenotype. 
This population of purified BMSCs was used in all experiments. For vasculogenic 
differentiation of BMSCs, the expanded and purified population of CD90+ BMSCs was 
seeded into the collagen-gel tubular scaffold and cultured either in vasculogenic or non-
vasculogenic culture medium for 28 days. At regular intervals of 7, 14, 21 and 28 days the 
tube cultures were assayed by RT-qPCR, immunofluorescence, ultrastructural and 
biochemical analyses for various endothelial and smooth muscle cell differentiation markers 
as shown in table 1 and 2. These times were chosen for the following reasons: these time 
points cover the range of both vasculogenic and angiogenic processes seen in vivo and/or in 
vitro and mimic the progression of microvascular development. 
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3. Research methods 
3.1 Fabrication of tubular scaffold 
Briefly, a 25 mg/ml solution of bovine collagen type I was extruded with a device that 
contained two counter-rotating cones. The liquid collagen was fed between the two cones 
and forced through a circular annulus in the presence of an NH3-air (50-50 vol/vol) 
chamber. This process results in a hollow cylindrical tube of aligned collagen fibrils with an 
inner central lumen. The dimensions of tubes produced for this set of experiments had a 
length of 30 mm with a luminal diameter of 4 mm and an external diameter of 5 mm, 
leaving a wall thickness of 1 mm. The collagen tubes had a defined fiber angle of 18° relative 
to the central axis of the tube and had pores ranging from 1 to 10 μm. The tubes were 
sterilized using gamma radiation 1200 Gy followed by Stratalinker UV crosslinker 1800 
(Stratagene) and then placed in Mosconas’s solution (in mM: 136.8 NaCl, 28.6 KCl, 11.9 
NaHCO3, 9.4 glucose, 0.08 NaH2PO4, pH 7.4) (Sigma-Aldrich) containing 1 µl/ml 
gentamicin (Sigma-Aldrich) and incubated in 5% CO2 at 37°C until cellular seeding 
(Valarmathi et al., 2010). The rationale for the particular orientation of collagen fiber was 
based on our previous work on cardiovascular tissue engineering (Yost et al., 2004). When 
proepicardial organ cells (PECs) were seeded onto this scaffold, they underwent maturation 
and differentiation and produced elongated vessel-like structures reminiscent of in vivo-like 
phenotype (Valarmathi et al., 2008). 
3.2 BMSCs isolation, expansion and maintenance   
The initial step is to isolate the mononuclear cells from the bone marrow by aspiration and 
centrifugation followed by plating and isolation of the cells based on differential adherence 
capacity to tissue culture dishes (passage 0 cells). Rat BMSCs were isolated from the bone 
marrow of adult 300g Sprague Dawley SD rats (Harlan Sprague Dawley, Inc.). Briefly, 
after deep anesthesia, the femoral and tibial bones were removed aseptically and cleaned 
extensively to remove associated soft connective tissues. The marrow cavities of these bones 
were flushed with Dulbecco’s Modified Eagle Medium (DMEM; Invitrogen) and combined. 
The isolated marrow plugs were triturated, and passed through needles of decreasing gauge 
(from 18 gauge to 22 gauge) to break up clumps and cellular aggregates. The resulting single-
cell suspensions were centrifuged at 200g for 5 minutes. Nucleated cells were counted using a 
Neubauer chamber. Cells were plated at a density of 5 X 106 – 2 X 107 cells per T75 cm2 flasks in 
basal medium composed of DMEM supplemented with 10% fetal bovine serum (FBS, lot-
selected; Atlanta Biologicals, Inc.), gentamicin (50 μg/ml) and amphotericin B (250 ng/ml) and 
incubated in a humidified atmosphere of 5% CO2 at 37°C for 7 days. The medium was 
replaced, and changed three times per week until the cultures become ~70% confluent 
(between 12 and 14 days). Cells were trypsinized using 0.05% trypsin-0.1% EDTA and re-
plated at a density of 1 x 106 cells per T75 cm2 flasks. After three passages, attached marrow 
stromal cells were devoid of any non-adhering population of cells. These passaged BMSCs 
were cryopreserved and stored in liquid nitrogen until further use (Valarmathi et al., 2011). 
3.3 Immunophenotyping of BMSCs by flow cytometry and confocal microscopy 
BMSCs are a heterogeneous population of cells with varying degrees of cell shapes and 
sizes. Stringent characterization of BMSCs used in experimental procedures is required for 
various cell surface markers; this is to ensure that the employed population of cells contains 
solely stem/progenitor cells. This will obviate the possible contaminating marrow-derived 
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endothelial cells and macrophages that are part of the adherent population of cultured cells. 
Therefore, characterization of BMSCs included qualitative evaluation for various cell surface 
markers and was performed on cells grown in the Lab-tekTM chamber slide systemTM (Nunc) 
using a Zeiss LSM 510 Meta confocal scanning laser microscope (Carl Zeiss, Inc.), and 
quantitative analysis of the same set of markers was performed by single-color flow 
cytometry using a Coulter® EPICS® XL™ Flow Cytometer (Beckman Coulter, Inc.) as 
previously described (Valarmathi et al., 2009).   
Immunophenotyping of undifferentiated BMSCs for various cell surface markers by flow 
cytometry revealed that the fluorescent intensity and distribution of the cells stained for 
CD11b, CD31 and CD45 were not significantly different from the intensity and distribution of 
cells stained with isotype controls (Figure 1E-G), indicating that these cultures were devoid of 
any possible hematopoietic stem and/or progenitor cells as well as differentiated bone-
marrow-derived endothelial cells. In contrast, BMSCs exhibited high expression of CD90 
surface antigens (Figure 1H), which is a consistent characteristic of undifferentiated BMSCs. 
Phenotypic characterization using the same set of markers on BMSCs by confocal microscopy 
also revealed that these cells were negative for CD11b, CD31 and CD45 (Figure 1A-C) and, 
strongly positive for CD90 (Figure 1D). The expression profiles of these surface molecules 
were consistent with previous reports and the minimal criteria for defining multipotent 
mesenchymal stromal cells, enunciated by the international society for cellular therapy (ISCT) 
position statement (Dominici et al., 2006; Valarmathi et al., 2009; Reyes et al., 2002). 
3.4 Purification and enrichment of CD90+ BMSCs by magnetic-activated cell sorting 
(MACS) 
Purification and enrichment of input BMSCs (such as CD45-, CD34-, CD90+/CD105+) are 
mandatory either using MACS (magnetic activated cell sorter) or FACS (fluorescent 
activated cell sorter). Since the unpurified fraction may contain sizable number of 
contaminating adherent macrophages and bone marrow-derived endothelial progenitors 
and differentiated endothelial cells. The adherent populations of BMSCs were further 
purified by indirect magnetic cell labeling method using an autoMACS Pro Separator 
(Miltenyi Biotech). Thus, these cells were subjected to CD90 positive selection by incubating 
the cells with FITC- labeled anti-CD90 antibodies (BD Pharmingen), followed by incubation 
with anti-FITC magnetic microbeads (Miltenyi Biotech), and passed through the magnetic 
columns as per the manufacturer’s instructions. The resultant enriched CD90+/CD34-
/CD45- fractions were expanded by subcultivation and subjected to flow cytometric analysis 
as described previously (Valarmathi et al., 2010). 
3.5 BMSCs vasculogenic differentiation 
For vasculogenic differentiation of BMSCs, the purified population of CD90+ BMSCs were 
seeded into the collagen-gel tubes at a density of 0.5 x 106 cells/30 mm tube length and 
cultured either in mesenchymal stem cell growth medium supplemented with 10% FBS, 
penicillin and streptomycin (Poietics MSCGM BulletKit; Lonza Ltd.) or microvascular 
endothelial cell growth medium (Clonetics EGM-MV Bullet Kit; Lonza Ltd.) 
supplemented with 5% FBS, bovine brain extract, human epidermal growth factor (hEGF), 
hydrocortisone, amphotericin B and gentamicin for 28 days. These BMSCs seeded tubes 
were cultured either in vasculogenic or non-vasculogenic medium for the defined time 
periods of 7, 14, 21 or 28 days. In addition, BMSCs were seeded in 65-mm Petri dishes at a 
density of 3 x 103 cells/cm2 and cultured either in non-vasculogenic (MSCGM) or 
vasculogenic (EGMMV) medium for 7, 14, 21 or 28 days.  
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Fig. 1. Immunophenotyping of undifferentiated rat BMSCs by confocal microscopy and 
flow cytometry. Immunostaining and confocal microscopy revealed that BMSCs were 
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negative for CD11b (A), CD 31 (B) and CD45 (C) and; were uniformly positive for CD90 
surface antigen (D), consistent with their undifferentiated state. Isotype and/or negative 
controls were included in each experiment to identify the level of background staining. 
Cells were also stained for nuclei (blue – DAPI). Additionally, the same population of 
BMSCs was subjected to flow cytometric analysis. Single parameter histograms showing 
the relative fluorescence intensity of staining (abscissa) and the number of cells analyzed, 
events (ordinate). Isotype controls were included in each experiment to identify the level 
of background fluorescence (black, shaded peaks). The intensity and distribution of cells 
stained for hematopoietic and endothelial markers; CD11b, CD31 and CD45 (grey, open 
peaks) were not significantly different from those of isotype control (black, shaded peaks) 
(E-G), indicating that these cultures were devoid of any potential contaminating 
hematopoietic and/or endothelial cells of bone marrow origin. The fluorescent intensity 
was greater (shifted to right) when BMSCs were stained with CD90 (grey) compared to 
isotype control (black) (H). The predominant population of BMSCs consistently  
expressed CD90 surface molecule, a property of rat bone marrow-derived 
mesenchymal/stromal stem cells. (DAPI - 4’,6-diamidino-2-phenylindole).  
Merged images A-D (A-D, scale bar 200 m). 
4. BMSCs based postnatal de novo vasculogenesis and in situ vascular 
regeneration 
The 3-D collagen-gel tubular scaffold has previously been used to create vascularized bone 
elements (Valarmathi et al., 2008 a, b). Here we report the utility of a 3-D tubular construct 
for its ability to support the vasculogenic differentiation of BMSCs culminating into 
microvascular structures, which are similar to those structures resulting from postnatal de 
novo vasculogenesis and angiogenesis (Valarmathi et al., 2008 a, b). 
In the developing vertebrate embryo, the initial event of blood vessel formation is the 
differentiation of vascular endothelial cells, which subsequently cover the entire interior 
surface of all blood vessels. Angioblasts are a subpopulation of primitive mesodermal cells 
that are committed to differentiate into endothelial cells and later on form the primitive 
vascular labyrinth (Risau & Flamme, 2000). In addition, endothelial cells can also arise from 
hemangioblasts, a common precursor for both hematopoietic and endothelial cells (His et 
al., 1900).  
In adults, endothelial precursor cells have been identified in bone marrow, peripheral blood 
and blood vessels (Prater et al., 2007). Two subsets of multipotential stem cells, HSCs and 
BMSCs/MSCs are resident in the postnatal bone marrow. Of these cells, BMSCs can be 
differentiated into osteoblasts, chondrocytes, adipocytes, smooth muscle cells and 
hematopoietic supportive stroma either in vitro or in vivo (Bianco et al., 2001). Previous 
studies have provided substantial evidence that bone-marrow-derived stem and/or 
progenitor cells can be differentiated into either endothelial or smooth muscle cells in vitro 
and in pathological situations are capable of contributing to neoangiogenesis in vivo by 
cellular integration (Carmeliet & Luttun, 2001).  
Although there are a plethora of studies focused on developing viable scaffolds  
for osteogenic, chondrogenic, adipogenic and musculogenic differentiation of BMSCs 
(Lanza et al., 2000), the optimal scaffolds that are capable of inducing and supporting  
the growth and differentiation of BMSCs into vascular cell lineages are yet to be  
identified and characterized. Despite the much known vasculogenic potential and 
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transgermal plasticity of BMSCs; none of these studies explicitly demonstrated the 
postnatal de novo vasculogenic potential of BMSCs in vitro (Reyes et al., 2002; Oswald et 
al., 2004). 
When compared to 2-D planar cultures, the potential 3-D models of vasculogenesis allow us 
to understand the role of specific factors under more physiological and spatial conditions 
with respect to dimensionality, architecture and cell polarity. Nevertheless, the molecular 
composition and the natural complexity and diversity of in vivo extra cellular matrix (ECM) 
organization cannot be easily mimicked or reproduced in vitro (Vailhe et al., 2001). In 
addition, even though quite a few in vitro 3-D models of vasculogenesis based on fibrin and 
collagen gels are in vogue (Folkman & Haudenschild, 1980); none have explored the 
behavior of BMSCs and their intrinsic vasculogenic differentiation potential on a 
topographically structured 3-D tubular scaffold made of uniformly aligned type I collagen 
fibers. 
Previous studies demonstrated that the formation of endothelial tubes in vitro was largely 
influenced by the nature of the substrate (Kleinman et al., 1982). The formation of 
endothelium lined tubular structures was enhanced when the substrate was rich in 
laminin (Madri et al., 1988), whereas a matrix rich in type I collagen would not promote 
rapid tubulogenesis (Montesano et al., 1983; Ingber & Folkman, 1989). Similarly, Ingber & 
Folkman (1989) documented that under a given cocktail of growth factors, the local 
physical nature of the interaction between endothelial cells and the underlying 
matrix/substrate ultimately determined the tubular morphogenesis. Substrates containing 
abundant fibronectin promoted adhesion, spreading and growth of endothelial cells. In 
contrast, less adhesive substrate or matrix materials that were arranged three-
dimensionally permitted the endothelial cells to retract and form tubes (Ingber & 
Folkman, 1989).  
In general, successful in vitro differentiation of cells depends on cell-cell as well as cell-
matrix interactions. Therefore, we hypothesized that under appropriate in vitro local 
environmental cues (combination of growth factors and ECM) multipotent postnatal BMSCs 
could be induced to undergo microvascular development. Hence, we developed a 3-D 
culture system in which a pure population of CD90+ rat BMSCs was seeded and cultured on 
a highly aligned, porous, biocompatible collagen-fiber tubular scaffold for differentiation 
purposes. Here, we utilized two types of growth media for vasculogenic differentiation 
purpose, MSCGM (non-vasculogenic) as control and EGMMV (vasculogenic) preferentially 
for microvascular differentiation. Both of these culture media consistently promoted the 
vasculogenic differentiation of BMSCs and also supported the formation of endothelium 
lined vessel-like structures within the constructs. 
A number of early and late stage markers associated with rodent vascular development in 
vivo were used in this study to characterize the rat BMSCs derived microvascular 
structures at mRNA and protein levels, which included: CD31/Pecam1, Flt1 (Vegfr1), Flk1 
(Vegfr2/Kdr), VE-cadherin (CD144), CD34, Tie1, Tek (Tie2), and Von Willibrand factor 
(Vwf). Platelet/endothelial cell adhesion molecule, also known as CD31, is a 
transmembrane protein expressed abundantly early in vascular development that may 
mediate leukocyte adhesion and migration, angiogenesis, and thrombosis (Albelda et al., 
1991). The other early stage differentiation markers Flk1 and Flt1, which are receptors for 
the vascular endothelial cell growth factor-A (Vegf) essentially, play a vital role in 
embryonic vascular and hematopoietic development (Shalaby et al., 1997). Similarly, VE-
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cadherin, a member of the cadherin family of adhesion receptors, is a specific and 
constitutive marker of endothelial cell plays an important role in early vascular assembly. 
Vascular markers that are expressed at a later stage include CD34 and Tie-2 (Bautch et al., 
2000). CD34 is a transmembrane surface glycoprotein that is expressed in endothelial cells 
and hematopoietic stem cells. Tie1 and Tek are receptor kinases on endothelial cells that 
are essential for vascular development and remodeling in the embryo and may also 
mediate maintenance and repair of the adult vascular system. In late phases of 
vasculogenesis, the mature endothelial cells will synthesize and secrete Vwf homolog, a 
plasma protein that mediates platelet adhesion to damaged blood vessels and stabilizes 
blood coagulation factor VIII. 
In any type of in vitro cellular differentiation, the cytodifferentiated cells need to be critically 
evaluated for their maturation and differentiation at transcriptional, translational and 
functional levels. Therefore, to study the expression pattern of key vasculogenic gene 
transcripts in the 3-D tube constructs; we examined the time-dependent expression pattern 
of Pecam1, Kdr, Tie1, Tek and Vwf at mRNA level in the tube constructs by real-time PCR 
(Table 1, Figure 2A-D).  
 
 
Genes Forward primer Reverse primer 
Product 
length 
(bp) 
Annealing 
temperature 
(°C) 
GenBank accession 
No 
Pecam1 5’–CGAAATCTAGGCCTCAGCAC–3’ 5’–CTTTTTGTCCACGGTCACCT–3’ 227 56 NM_03159.1 
Kdr 5’–TAGCGGGATGAAATCTTTGG–3’ 5’–TTGGTGAGGATGACCGTGTA–3’ 207 56 NM_013062.1 
Tie1 5’–AAGGTCACACACACGGTGAA–3’ 5’–TGGTGGCTGTACATTTTGGA–3’ 174 56 XM_233462.4 
Tek 5’–CCGTGCTGCTGAACAACTTA–3’ 5’–AATAGCCGTCCACGATTGTC–3’ 201 56 NM_001105737.1 
Vwf 5’–GCTCCAGCAAGTTGAAGACC–3’ 5’–GCAAGTCACTGTGTGGCACT–3’ 163 56 XM_342759.3 
Gapdh 5’–TTCAATGGCACAGTCAAGGC–3’ 5’–TCACCCCATTTGATGTTAGCG–3’ 101 56 XR_007416.1 
Table 1. RT-qPCR primer sequences used in this study (Valarmathi et al., 2009; Rozen and 
Skaletsky, 2000). 
Constitutive expressions of these markers were detected at low to very low levels in 
undifferentiated BMSCs. RT-qPCR results showed that differentiation of BMSCs under 
vasculogenic tube culture conditions for 28 days resulted in increased expression of 
transcripts coding for various endothelial cell associated proteins such as Pecam1, Kdr, 
Tek and Vwf. The peak expression of Vwf, the endothelial specific protein occurred 
around day 21 (over 400 fold) indicating that the differentiating cells acquired a 
distinctive phenotype and biosynthetic activity of differentiated and matured endothelial 
cells (Figure 2D). The upregulation of Tek during this period may represent the continual 
development and remodeling of the developing microvessels within the tubular 
constructs. Whereas differentiation of BMSCs under non-vasculogenic tube culture 
conditions for 14 days showed signs of early and rapid induction of transcripts coding for 
both early and late stage endothelial cell markers such as Kdr, Tie1, Tek and Vwf. The 
peak expression of Vwf occurred during day 14 (over 20 fold) (Figure 2B) (Valarmathi et 
al., 2009).   
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Fig. 2. Real-time reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) 
analysis of various key vasculogenic markers. RT-qPCR analysis of various key 
vasculogenic markers such as tyrosine kinase with immunoglobulin-like and EGF-like 
domains 1 (Tie1), endothelial-specific receptor tyrosine kinase (Tek/Tie2), 
platelet/endothelial cell adhesion molecule 1 (Pecam1), kinase insert domain protein 
receptor (Kdr/Flk1/Vegfr-2), and Von Willebrand factor homology (Vwf) as a function of 
time (abscissa). BMSCs cultured in Petri dishes (2-D culture) in mesenchymal stem cell 
growth medium (A) and, in microvascular growth medium (C). BMSCs cultured in 
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collagen-gel tubular scaffolds (3-D culture) in mesenchymal stem cell growth medium (B) 
and, in microvascular growth medium (D). The calibrator control included BMSCs day 0 
sample and; the target gene expression was normalized by a non-regulated reference gene 
expression, Gapdh. The expression ratio (ordinate) was calculated using the REST-XL 
version 2 software. The values are means ± standard errors for three independent cultures 
(n=3). (Tie-1 and Tek – plotted with respect to 1 Y-axis; Pecam-1, Kdr and Vwf – plotted 
with respect to 2 Y-axis) (Pfaffl, 2001, 2002; Valarmathi et al., 2008 a). 
As revealed by immunostaining for various vasculogenic markers, day 21 vasculogenic and 
non-vasculogenic tube cultures showed that BMSCs were able to adhere, proliferate, 
migrate and, undergo complete maturation and differentiation into microvascular structures 
(Figure 3A-C). BMSCs derived microvessel formation is a combination of de novo 
vasculogenesis i.e., in situ endothelial cell differentiation and endothelium-lined tube 
formation, and angiogenesis, endothelial sprouting from existing endothelial tubes. In 
addition, these microvessels are stabilized by association with BMSCs derived smooth 
muscle cells and/or pericytes. 
 
 
 
Fig. 3. Localization of BMSC-derived endothelial cells by Texas Red labeled Lycopersicon 
Esculentum lectin/Tomato Lectin (LEL/TL) staining. BMSCs cultured in collagen-gel 
tubular scaffolds under vasculogenic or non-vasculogenic culture conditions were incubated 
with tomato lectin (1:50 in 10 mM N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, pH 
7.5; 0.15 M NaCl) to identify endothelial cells. Confocal laser scanning microscopic analysis 
of day 14 tubular scaffolds in these media conditions demonstrated the typical cobblestone 
appearance of differentiating endothelial cells (A), fusion and self-assembly (B), and 
evolving primitive capillary plexus with attempted lumen formation (B-C, white arrows). 
Cells were also stained for nuclei (blue, DAPI). Image (A) shows a projection representing 19 
sections collected at 5.05 μm intervals (90.90 μm). Image (B) shows a projection representing 
13 sections collected at 4.05 m intervals (48.60 m). Image (C) shows a projection 
representing 15 sections collected at 6 m intervals (84.00 m). Merged images (A-C).  
(A-B, scale bar 100 m; C, scale bar 50 m). 
To validate the findings of mRNA expression pattern of important vasculogenic markers in 
these tube cultures and to determine whether these messages were in fact translated into 
proteins, immunostaining of the BMSC tube culture was carried out (Table 2; Figure 4A-L; 
Figure 5A-L).  
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Fig. 4. Expression pattern of various vasculogenic markers in tubular scaffold by confocal 
microscopy. Localization of key endothelial and smooth muscle cell phenotypic markers of 
day 21 vasculogenic and non-vasculogenic tube cultures demonstrated the expression of 
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Flk1 (A, C), VE-cadherin (D, F), Vwf (G, I), CD34 (J, L), tomato lectin (E, F) and -SMA (B-C, 
H-I, K-L). Dual immunostainings of these tube cultures (mesenchymal stem cell growth 
media, MSCGM or microvascular endothelial growth medium, EGMMV) revealed areas of 
elongated and flattened cells composed of varying degrees of mature endothelial and 
smooth muscle cells (A-L). These cells were organized into a loose delicate monomer 
network of nascent capillary-like structures composed of mature endothelial and smooth 
muscle cells. In addition, tube-like structures were emanating from the mixed population of 
differentiating vasculogenic cells represented by their distinct morphology and phenotypic 
expression (white arrows, A-C; white arrows, G-L). Cells were also stained for nuclei (blue, 
DAPI). Images (A-C) show a projection representing 15 sections collected at 3.05 m 
intervals (42.70 μm). Images (J-L) show a projection representing 15 sections collected at 5.05 
m intervals (70.70 μm). Merged images (A-L). (A-C, scale bar 100 m; D-L, scale bar 50 m). 
Adapted from Valarmathi et al., 2009. 
 
Primary antibodies Dilutions Source Cell target 
BMSCs characterization markers 
CD11b 
 
1:50
 
BD Pharmingen
 
Leukocytes 
CD31 1:10 Abcam Endothelial  
CD45 1:50 BD Pharmingen Hematopoietic 
CD90 1:50 BD Pharmingen BMSCs 
Endothelial cell differentiation markers    
CD34 1:100 Santa Cruz Biotechnology Endothelial 
Flk-1 1:100 Santa Cruz Biotechnology Endothelial 
VE- cadherin 1:100 Santa Cruz Biotechnology Endothelial  
Pecam1 1:100 Santa Cruz Biotechnology Endothelial 
Vwf 1:100 Santa Cruz Biotechnology Endothelial 
Tomato lectin 1:50 Vector Laboratories Endothelial 
Smooth muscle cell differentiation markers    
α-SMA 1:100 Sigma-Aldrich Smooth muscle 
Table 2. Primary antibodies used in this study (Valarmathi et al., 2009). 
It is well known that endothelial cells share a large majority of their characteristic antigenic 
markers with other types of hematopoietic and mesenchymal cells (Bertolini et al., 2006). 
Therefore, antigens such as CD31, CD34, CD144 (VE-cadherin), CD146, Vwf or CD105 are 
not only expressed by endothelial cells but also expressed by hematopoietic cells 
(specifically HSCs), platelets and certain subpopulations of fibroblasts. Hence to identify the 
differentiated and matured endothelial cells in the tubular scaffold a battery of various early 
and late stage vasculogenic markers such as Pecam1, CD34, Flt1, Flk1, VE-cadherin and Vwf 
were employed. In addition, tomato lectin, another marker specific for rat vascular 
endothelial cells, was found closely associated with Flk1 and Vwf staining. These 
endothelial associated markers localized to endothelial cell clusters and capillary-like 
structures that were present throughout the tubular construct. This suggests that BMSC-
derived endothelial cells assembled into endothelium-lined tube-like structures and 
initiated the process of vasculogenesis, consistent with our previous report (Valarmathi et 
al., 2008). In addition, the BMSC-derived cells and the microvessel-like structures expressed 
the smooth muscle antigens, α-SMA. These α-SMA positive cells were recruited in 
juxtaposition to the tandemly arranged endothelial cells and, were attached and wrapped 
around in such a way that is reminiscent of in vivo microvessel morphogenesis.  
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Fig. 5. Expression pattern of various vasculogenic markers in tubular scaffold by confocal 
microscopy. Localization of key endothelial and smooth muscle cell phenotypic markers 
of day 21 vasculogenic and non-vasculogenic tube cultures demonstrated the expression 
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of Pecam1 (A, C), Vwf (D, F; J, L), VE-cadherin (G, I), tomato lectin (H-I; K-L) and -SMA 
(B-C, E-F). Dual immunostainings of these tube cultures (mesenchymal stem cell growth 
media, MSCGM or microvascular endothelial growth medium, EGMMV) revealed areas 
of elongated cells composed of both mature endothelial and smooth muscle cells (A-L). 
These cells were organized into a loose delicate network of nascent capillary-like 
structures composed of mature endothelial and smooth muscle cells and showed evidence 
of central lumen formation (white arrows, A-C, G-I). These cells formed developing 
microvessel-like structures (D-L). The linear nascent capillary-like structures showed 
translucent central lumen (white arrows, G-I). In addition, the cells were organized into a 
loose network of vascular cells and were in a ribbon-like configuration (D-F). These 
aligned vascular cells transformed into thin tube-like structures reminiscent of in vivo 
microvessel morphogenesis (D-L). Cells were also stained for nuclei (blue, DAPI). Images 
(A-C) show a projection representing 19 sections collected at 5.05 μm intervals (90.90 μm). 
Images (D-F) show a projection representing 16 sections collected at 4.05 μm intervals 
(60.75 μm). Images (G-I) show a projection representing 13 sections collected at 3.05 μm 
intervals (36.60 μm). Images (J-L) show a projection representing 23 sections collected at 
4.05 μm intervals (89.10 μm). Merged images (A-L). (A-L scale bar 50 m). Adapted from 
Valarmathi et al., 2009. 
Similarly, it is critically important to characterize the ultrastructural morphology of any 
stem cells that are directed to differentiate into vascular lineage cells. Scanning electron 
microscopic (SEM) analysis of the tubular constructs depicted the pattern of microvessel 
morphogenesis and maturity. These formed nascent capillary-like structures and elongated 
tube-like structures revealed patent lumen-like structures, elucidating the vessel-maturation 
(Figure 6A-H). Besides, transmission electron microscopic (TEM) analysis revealed 
elongated capillary-like structures lined by differentiating endothelial cells (Figure 7A-F). 
These cells showed electron dense bodies as well as numerous small pinocytotic vesicles 
adjacent to the endothelial cell membranes as well as in their cytoplasm (Figure 7B, black 
arrows). In addition these cells exhibited variously sized cell-cell junctions, which have the 
appearance of typical in vivo endothelial tight junctions (Figure 7C-F).  
Furthermore, the ability to identify endothelial cells based on their increased metabolism of 
Ac-LDL was examined using Ac-LDL tagged with the fluorescent probe, Dil-Ac-LDL. 
BMSC-derived endothelial cells and the nascent capillary-like structures were brilliantly 
fluorescent whereas the fluorescent intensity of smooth muscle cells/pericytes was barely 
detectable as reported previously (Valarmathi et al., 2009). This suggests that the formed 
endothelial cells were not only fully differentiated but also functionally competent and 
matured (Figure 8A-C).  
This behavior of BMSCs and their exhibition of vasculogenic differentiation potential can be 
attributed to the nature of microenvironmental factors in this culture conditions. The 
preconditioned factors in the growth microenvironment rendered by the aligned type I 
collagen fibers of the tubular scaffold and the soluble differentiating factors provided by the 
vasculogenic or non-vasculogenic medium may be behind the BMSC fate determination. 
Further work is ongoing to determine whether our prevascularised tubular scaffolds can 
survive implantation into a tissue defect and is able to anastomose promptly with vascular 
sprouts emanating from the host. Finally, our morphological, molecular, immunological and 
biochemical data reveal the intrinsic vasculogenic differentiation potential of BMSCs under 
appropriate 3-D environmental conditions. 
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Fig. 6. Scanning electron microscopic (SEM) analysis of tubular constructs. SEM analysis of 
day 28 tubular constructs under vasculogenic or non-vasculogenic culture conditions 
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showed the typical cobblestone appearance of differentiating endothelial cells (A), 
stratification and networking (B-D), and the presence of smooth-walled tube-like structures 
with its attached smooth muscle cells and/or pericytes (black arrows, F-H). Multiple smooth 
muscle-like cells were wrapping around these tube-like structures (black asterisks, Figure E-
H). These cylindrical structures revealed the presence of evolving patent lumens (white 
asterisks, C, G, H). (A-H, scale bar 10 m). Adapted from Valarmathi et al., 2009. 
 
 
Fig. 7. Transmission electron microscopic (TEM) analysis of tubular constructs. TEM analysis of 
day 28 tubular constructs under vasculogenic or non-vasculogenic culture conditions showed a 
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vessel-like structure containing many small dense bodies within endothelial cells on either side 
of the lumen (A). Note the most obvious feature of endothelial cells, the concentration of small 
vesicles (pinocytotic vesicles) adjacent to the endothelial cell membranes and cytoplasm (B, black 
arrows). The interdigitating endothelial cells showing junctional regions (C, E, inserts, lower 
magnification). The typical adherent junction could be visualized between two overlapping 
endothelial cell processes (D, F, inserts, higher magnification). (Hanaichi et al., 1986). 
 
 
Fig. 8. Characterization of BMSC-derived endothelial cells by Dil-Ac-LDL uptake. BMSCs 
cultured in collagen-gel tubular scaffolds in vasculogenic or non-vasculogenic culture 
conditions were incubated with 10 g/ml of Dil-Ac-LDL for 4 to 6 hours. Confocal laser 
scanning microscopic analysis of day 21 tubular scaffolds in microvascular endothelial cell 
growth medium (EGMMV) revealed typical abundant punctate perinuclear bright red 
fluorescence of the differentiated and matured endothelial cells (A). These labeled vascular 
cells were self-organized into tangled nascent linear capillary-like structures (B), assembled 
into solid cord of cells and, transformed into tube-like structure with attempted lumen 
formation (C, white arrows). Cells were also stained for nuclei (blue, DAPI). Image (C) shows a 
projection representing 22 sections collected at 5 μm intervals (105.00 μm). Merged images (A-
C). (A-C, scale bar 50 m). (Voyta et a., 1984) (Adapted from Valarmathi et al., 2009) 
Previously, it has been shown that mature vascular endothelium can give rise to smooth 
muscle cell (SMC) via endothelial-mesenchymal transdifferentiation, coexpressing both 
endothelial and SMC-specific phenotypic markers (Frid et al., 2002). Recently, it has been 
show that Flk1-expressing blast cells derived from embryonic stem cells can act as 
precursors that can differentiate into both endothelial and mural cell populations of the 
vasculature (Yamashita et al., 2000). In this study, clonal analyses revealed the bi-lineage 
potential of BMSCs, suggesting that both endothelial and smooth muscle/pericytes could be 
derived from single colonies. However, in general, BMSCs-derived colonies are clonal or 
nearly clonal. The colonies of BMSCs resultant from a number of cells may represent co-
existence of several subclones, each capable of differentiating into specific lineages. Hence, 
single cell-derived colonies that are stably transfected with lineage specific markers are 
needed to gain more meaningful insights and address the origin of both lineages.  
Our results indicate that the 3-D tubular scaffold with its unique characteristics provides a 
favorable microenvironment that permits the development of in situ microvascular 
structures. Moreover, this is the first ever documentation that explicitly demonstrates that 
adult BMSCs under appropriate in vitro environmental cues can be induced to undergo 
vasculogenic differentiation culminating in microvessel morphogenesis (Valarmathi et al., 
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2009). Our model recapitulates many aspects of in vivo de novo vasculogenesis. Thus, this 
unique culture system provides an in vitro model to investigate the maturation and 
differentiation of BMSC-derived vascular endothelial and smooth muscle cells in the context 
of postnatal vasculogenesis. In addition, it allows us to elucidate various molecular 
mechanisms underlying the origin of both endothelial and smooth muscle cells and 
especially to gain a deeper insight and validate the emerging concept of ‘one cell and two 
fates’ hypothesis of vascular development (Yamashita et al., 2000). 
5. Conclusions 
Here we report a unique 3-D culture system that recapitulates many aspects of postnatal de 
novo vasculogenesis. This is the first comprehensive report that evidently demonstrates that 
BMSCs under appropriate in vitro environmental conditions can be induced to undergo 
vasculogenic differentiation culminating in microvessels. Since BMSCs differentiated into 
both endothelial and smooth muscle cell lineages, this in vitro model system provides a tool 
for investigating the cellular and molecular origin of both vascular endothelial cells and 
smooth muscle cells. In addition, this system can potentially be harnessed to develop in 
vitro engineering of microvascular trees, especially using autologous bone-marrow-derived 
BMSCs for therapeutic purposes in regenerative medicine. 
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